Trulieve Cannabis Corp. (TCNNF)

Market Cap	1.96B
Revenue (ttm)	1.15B
Net Income (ttm)	-495.29M
Shares Out	190.29M
EPS (ttm)	-2.62
PE Ratio	n/a
Forward PE	20.41
Dividend	n/a
Ex-Dividend Date	n/a

Volume	104,891
Open	10.50
Previous Close	10.42
Day's Range	10.13 - 10.52
52-Week Range	3.42 - 14.50
Beta	1.38
Analysts	Strong Buy
Price Target	13.88 (+34.5%)
Earnings Date	Aug 9, 2023

About TCNNF

Trulieve Cannabis Corp., together with its subsidiaries, operates as a cannabis retailer. The company cultivates, processes, and manufactures cannabis products and distributes its products to its dispensaries, as well as through home delivery. It sells flowers, edibles, vapes, creams, balms, salves, lotions, vaporizers, batteries, cartridge, concentrates, topicals, capsules, synringes, tinctures, and accessories under the Avenue, Cultivar Collection, Muse, Modern Flower, Alchemy, Momenta, Sweet Talk, Co2lors, Loveli, Trekkers, and Roll One bran...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1940
• Employees: 5,400
• Stock Exchange: OTCMKTS
• Ticker Symbol: TCNNF

Financial Performance

In 2023, TCNNF's revenue was $1.15 billion, a decrease of -7.25% compared to the previous year's $1.24 billion. Losses were -$536.46 million, 161.6% more than in 2022.

Analyst Forecast

According to 4 analysts, the average rating for TCNNF stock is "Strong Buy." The 12-month stock price forecast is $13.88, which is an increase of 34.50% from the latest price.

Price Target

$13.88

(34.50% upside)

Analyst Consensus: Strong Buy